Effects of ACL myotoxin, a Lys49 phospholipase A(2) from Agkistrodon contortrix laticinctus snake venom, on water transport in the isolated toad urinary bladder.
ACL myotoxin (ACLMT) is a Lys49 phospholipase A(2)-like protein isolated from the venom of the snake Agkistrodon contortrix laticinctus. The aim of this work was to study the effect of ACLMT on water transport in the toad bladder. Water flow through the membrane was measured gravimetrically in bag preparations of the bladder. ACLMT (20 nM) increased the baseline water flow and partially inhibited arginine-vasopressin (AVP), 8-chlorophenylthio-cAMP (8-CPT-cAMP) and forskolin-stimulated water flow. The effect of ACLMT on baseline or AVP-stimulated water flow was prevented by lanthanum (0.1 mM) indicating that the effect of ACLMT on water transport may be mediated through an increase in intracellular calcium. The effect of ACLMT on baseline water flow was also prevented by nifedipine (0.1 mM) indicating the participation of exogenous calcium in this effect. Carbachol (0.1 mM) has been shown to enhance baseline water flow while inhibiting AVP-stimulated water flow. The effects of ACLMT and carbachol on baseline water flow and AVP-stimulated water flow were not additive, suggesting that both agents alter water transport by a similar mechanism. Indomethacin (10 microM) reduced the effect of ACLMT on forskolin-stimulated water flow, suggesting an increase in prostaglandin biosynthesis. These results suggest that the effects of ACLMT on water transport may be mediated by increasing intracellular calcium and stimulation prostaglandin biosynthesis.
Leite
R S
RS
Departamento de Ciências Fisiológicas, Universidade Federal de São Carlos, Rodovia Washington Luis km 235, São Carlos, SP 13565-905, Brazil.
Franco
W
W
Ownby
C L
CL
Selistre-de-Araujo
H S
HS
D017836:Agkistrodon; D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism; D001692:Biological Transport / Q000187:drug effects; D002024:Bufo marinus; D002118:Calcium / Q000378:metabolism*; D003435:Crotalid Venoms / Q000201:enzymology / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D054501:Group II Phospholipases A2; D009498:Neurotoxins / Q000633:toxicity*; D009995:Osmosis / Q000187:drug effects; D010741:Phospholipases A / Q000494:pharmacology* / Q000633:toxicity*; D030162:Reptilian Proteins; D001743:Urinary Bladder / Q000187:drug effects / Q000378:metabolism*; D014867:Water / Q000378:metabolism*
D003435:Crotalid Venoms; D009498:Neurotoxins; D030162:Reptilian Proteins; D014867:Water; D001127:Arginine Vasopressin; D010741:Phospholipases A; C485038:ACL myotoxin, A contortrix; D054501:Group II Phospholipases A2; D002118:Calcium